Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM)…
Blog
FDA’s Moderna decision demonstrates how science and government are incompatible
Last week, the FDA announced that it would not be considering Moderna’s application for a new flu vaccine because the control group Moderna…
Op-Eds
Reform Obamacare, Don’t Just Extend It
Obamacare must be reformed, not just extended, as the House recently voted to do. Intended as a program to help people gain insurance…
Freedom Works Radio
Jeremy Nighohossian, Competitive Enterprise Institute “Trump Healthcare Plan a Mixed Bag”: Freedom Works Radio Show
Freedom Works Radio show interviews CEI’s expert on healthcare Listen to Freedom Works Radio…
The Lars Larson Show
The Lars Larson Northwest Podcast
The Lars Larson Show interviewed CEI’s expert on Healthcare Listen to more on The Lars Larson Show…
PCMA
ICYMI: CEI Warns Against Government Interference In the Pharmacy Industry Limiting Consumer Choice
PCMA cited CEI’s expert on Pharmacy Industry In case you missed it, a recent study from the Competitive Enterprise Institute (CEI) warns…